IE
EVFM

Israel Englander’s Evofem Biosciences, Inc. Common Stock EVFM Stock Holding History

Israel Englander’s Portfolio EVFM Stock Details EVFM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-37,160
Closed -$42K – 7875
2022
Q2 		$42K Buy
37,160
+19,732
+113% +$32.5K ﹤0.01% 6260
2022
Q1 		$89K Sell
17,428
-17,343
-50% -$109K ﹤0.01% 6201
2021
Q4 		$196K Sell
34,771
-8,571
-20% -$72.9K ﹤0.01% 5921
2021
Q3 		$480K Sell
43,342
-201,229
-82% -$2.53M ﹤0.01% 5391
2021
Q2 		$4.14M Buy
244,571
+221,239
+948% +$4.19M ﹤0.01% 3005
2021
Q1 		$612K Buy
23,332
+3,401
+17% +$155K ﹤0.01% 4654
2020
Q4 		$720K Buy
19,931
+18,704
+1,524% +$676K ﹤0.01% 3948
2020
Q3 		$43 Sell
1,227
-117,341
-99% -$5.1M ﹤0.01% 4306
2020
Q2 		$5.03M Buy
+118,568
New +$7.99M 0.01% 1763
2019
Q4 		– Sell
-1,057
Closed -$79K – 4785
2019
Q3 		$79K Buy
+1,057
New +$81.2K ﹤0.01% 3994
2019
Q2 		– Sell
-6,886
Closed -$362K – 4646
2019
Q1 		$362K Sell
6,886
-310
-4% -$16.8K ﹤0.01% 3445
2018
Q4 		$452K Sell
7,196
-4,511
-39% -$248K ﹤0.01% 3027
2018
Q3 		$711K Sell
11,707
-37,211
-76% -$1.61M ﹤0.01% 3058
2018
Q2 		$1.99M Buy
48,918
+48,177
+6,502% +$3.79M ﹤0.01% 2407
2018
Q1 		$71K Buy
+741
New +$95.1K ﹤0.01% 3512
2017
Q2 		– Sell
-124
Closed -$18K – 4012
2017
Q1 		$18K Buy
+124
New +$16.1K ﹤0.01% 3429
2015
Q2 		– Sell
-406
Closed -$300K – 4004
2015
Q1 		$300K Sell
406
-6
-1% -$3.83K ﹤0.01% 3045
2014
Q4 		$278K Buy
+412
New +$311K ﹤0.01% 3400

Other funds holding EVFM

CS
Clear Street New York $39.5B AUM 124.03% 1-Year Est. Return
AWM
Activest Wealth Management Aventure, Florida $518M AUM 44.34% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $761M AUM 39.85% 1-Year Est. Return
LTI
Laffer Tengler Investments Nashville, Tennessee $782M AUM 33.6% 1-Year Est. Return

Israel Englander's EVFM Position: Q3 2022 in Review

Israel Englander sold out of Evofem Biosciences, Inc. Common Stock (EVFM) in Q3 2022, closing a stake of 37,160 shares — an estimated $42K sold.

Israel Englander first reported a position in EVFM in Q4 2014 and held it in 18 quarters. The position peaked at $5.03M in Q2 2020. 8 funds tracked by Wall St. Rank hold EVFM as of Q3 2022.

  • Israel Englander reported no remaining Evofem Biosciences, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Israel Englander sold 37,160 Evofem Biosciences, Inc. Common Stock shares in Q3 2022, an estimated $42K.
  • Israel Englander first reported a position in Evofem Biosciences, Inc. Common Stock in Q4 2014 and held it in 18 quarters.
  • Israel Englander's Evofem Biosciences, Inc. Common Stock position peaked at $5.03M in Q2 2020.
  • 8 funds tracked by Wall St. Rank held Evofem Biosciences, Inc. Common Stock as of Q3 2022.

Based on Millennium Management's 13F filing for Q3 2022, filed 14 Nov 2022.